A pectic polysaccharide from Lycium ruthenicum Murray alleviates dextran sulfate sodium-induced colitis in mice

Dai Dong1, Hailiang Wang2, Hongtao Bi3

  • 1Department of Immunology, College of Basic Medical Sciences, Jilin University, 126 Xin min Street, Changchun, 130021, China.

PubMed

Insights

Lycium ruthenicum polysaccharide (LRWP-Ap) alleviates inflammatory bowel disease (IBD) symptoms in mice. It enhances gut barrier function, reduces inflammation, and balances gut microbiota, showing potential as a functional food for gut health.

Area of Science:

  • Gastroenterology
  • Immunology
  • Pharmacology

Background:

  • Inflammatory bowel disorders (IBD) present severe health risks, including perforation, bleeding, and colon cancer.
  • Lycium ruthenicum Murray (L. ruthenicum), a fruit rich in polysaccharides, has a long history of traditional use.
  • Polysaccharides from L. ruthenicum are explored for their therapeutic potential in managing gut health.

Purpose of the Study:

  • To investigate the protective effects of a specific pectic polysaccharide from L. ruthenicum (LRWP-Ap) on dextran sulfate sodium (DSS)-induced colitis in mice.
  • To elucidate the mechanisms underlying LRWP-Ap's therapeutic actions on the gut.

Main Methods:

  • Isolation and characterization of a pectic polysaccharide (LRWP-Ap) from L. ruthenicum fruit.
  • Induction of colitis in mice using DSS and subsequent oral administration of LRWP-Ap.
  • Assessment of disease severity, intestinal barrier function (tight junction proteins), inflammatory markers (pro- and anti-inflammatory cytokines), immune cell balance (Treg/Th17), arginine metabolism (Arg-1/iNOS), gut microbiota composition, and short-chain fatty acid (SCFA) levels.

Main Results:

  • LRWP-Ap administration significantly alleviated DSS-induced colitis symptoms in mice.
  • Treatment with LRWP-Ap enhanced intestinal barrier function by increasing tight junction protein levels (ZO-1, Occludin, Claudin 1).
  • LRWP-Ap modulated arginine metabolism, reduced pro-inflammatory factors, increased anti-inflammatory IL-10, and rebalanced Treg/Th17 cells, thereby maintaining intestinal immune homeostasis. Gut microbiota and SCFA levels were also favorably modulated.

Conclusions:

  • The pectic polysaccharide LRWP-Ap from L. ruthenicum demonstrates significant potential in alleviating IBD symptoms.
  • LRWP-Ap exerts protective effects by strengthening the intestinal barrier, regulating immune responses, and modulating gut microbiota.
  • L. ruthenicum shows promise as a natural functional food ingredient for improving gut health in conditions like DSS-induced colitis.